Charles A. Sninsky - Gainesville VA Medical Center and the Department of Medicine, University of Florida

基本信息

浏览量：44

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 75 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Prior Biologic Exposure on the Long-Term Durability of Clinical and Mucosal Efficacy in Patients with Ulcerative Colitis Treated with Ozanimod

Jordan Axelrad,Maia Kayal,Ailsa Hart,Charles Sninsky,Raymond K. Cross,Dimpy Mehra,Hsiuanlin Wu,Mark T. Osterman,Harris A. Ahmad,Anjali Jain,Walter Reinisch

AMERICAN JOURNAL OF GASTROENTEROLOGY（2023）

引用0浏览0引用

S894 Effects of Early Mucosal Healing at Week 10 Using Stringent Criteria in Patients with Ulcerative Colitis Treated with Ozanimod on Clinical Outcomes at Week 52

Jordan E. Axelrad,Ailsa Hart,Charles A. Sninsky,Raymond K. Cross,Harris A. Ahmad,Anjali Jain,H Wu,Mark T. Osterman,Randy Longman,Walter Reinisch

The American journal of gastroenterologyno. 10S (2023): S666-S667

引用0浏览0引用

P431 Early Mucosal Healing at Week, 10 with Ozanimod Predicts Clinical Outcomes at Week, 52: Post Hoc Analysis of the Phase, 3 True North Clinical Trial

Walter Reinisch,Jordan E. Axelrad,Harris A. Ahmad,Marc Pondel,Shabana Ather,Ayanbola Elegbe,Charles A. Sninsky,Randy Longman

Journal of Crohn s and Colitis（2022）

引用3浏览0引用

S731 Ozanimod is an Effective Oral Treatment for Patients with Ulcerative Colitis Regardless of Baseline Endoscopic Disease Distribution: A Post Hoc Analysis of the Phase 3 True North Study

Anita Afzali,Axel Dignass,Monika Fischer,Charles Sninsky, Alessandro Armuzzi,Chun Wu,Harris A. Ahmad,Arteid Memaj,Sarah Harris,James B. Canavan, Stefan Schreiber

American Journal of Gastroenterologyno. 10S (2022)

引用0浏览0引用

Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Baseline Endoscopic Disease Distribution: A Post Hoc Analysis of the Phase 3 True North Study

Anita Afzali,Axel Dignass,Monika Fischer,Charles Sninsky, Alessandro Armuzzi,Chun Wu,Harris A. Ahmad,Arteid Memaj,Sarah Harris,James B. Canavan,Stefan Schreiber

AMERICAN JOURNAL OF GASTROENTEROLOGYno. 10 (2022): S513-S514

引用0浏览0引用

Tu1464: EARLY MUCOSAL HEALING AT WEEK 10 WITH OZANIMOD PREDICTS CLINICAL OUTCOMES AT WEEK 52: POST HOC ANALYSIS OF THE PHASE 3 TRUE NORTH CLINICAL TRIAL

Randy Longman,Jordan E. Axelrad,Harris Ahmad,Marc Pondel,Shabana Ather,Ayanbola Elegbe,Charles Sninsky,Walter Reinisch

Gastroenterologyno. 7 (2022): S-972

引用0浏览0引用

460 RAPID INDUCTION EFFECTS OF OZANIMOD ON CLINICAL SYMPTOMS AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE INDUCTION PHASE OF TRUE NORTH

Mark T. Osterman,Randy Longman,Charles Sninsky,Stephen B. Hanauer,Brian G. Feagan,Denesh Chitkara,Steven Y. Hua,AnnKatrin Petersen,Anita Afzali,Terry P. Ponich,Britta Siegmund,William J. Sandborn

Gastroenterology（2021）

引用5浏览0引用

International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey

David T Rubin,Charles Sninsky,Britta Siegmund,Miquel Sans,Ailsa Hart,Brian Bressler,Yoram Bouhnik,Alessandro Armuzzi,Anita Afzali

INFLAMMATORY BOWEL DISEASES（2021）

引用27浏览0WOS引用

Definition of remission in inflammatory bowel disease: assessment of patient and physician perspectives

David Rubin,Charles Sninsky,Britta Siegmund,Miquel Sans,Ailsa Hart,Brian Bressler,Yoram Bouhnik,Alessandro Armuzzi,Anita Afzali

GASTROENTEROLOGYno. 3 (2020): S124-S125

引用0浏览0引用

Su1823 PATIENT AND PHYSICIAN PERSPECTIVES ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: DISEASE REMISSION AND DURABILITY OF TREATMENT

Anita Afzali,Alessandro Armuzzi,Yoram Bouhnik,Brian Bressler,Ailsa Hart,David T. Rubin,Miguel Sans,Britta Siegmund,Charles Sninsky

Gastroenterology（2020）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn